Ignite Creation Date:
2025-12-25 @ 3:00 AM
Ignite Modification Date:
2026-01-08 @ 5:23 AM
Study NCT ID:
NCT00629733
Status:
COMPLETED
Last Update Posted:
2011-06-08
First Post:
2008-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of a New Ultra Low Molecular Weight Heparin (RO-14) Administered Subcutaneously Increasing Single-doses to Healthy Male Volunteers
Sponsor:
Rovi Pharmaceuticals Laboratories
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ROV-RO14-2006-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr. Barbanoj
Old Organization:
Hospital Santa Creu i Sant Pau